LEKLI sh.p.k hereby informs that the Ministry of Health and Social Protection, pursuant to Article 5 of Law No. 105/2014, dated 31.07.2014 “On Drugs and Pharmaceutical Service”, as amended, and Chapter XI, paragraph 11.1 of Decision of Council of Ministers No. 359, dated 29.04.2015 “On the approval of the Regulation on the Principles and Good Practice Guidelines for Human Drug Manufacturing in the Republic of Albania”, upon proposal of the Drug Manufacturing Conditions Verification Committee in the Republic of Albania, has approved the Authorization for the GMP “Human Drug Manufacturing”.
“I am very happy to inform that the Minister of Health and Social Protection, based on the proposals of the DMCVC RoA, has approved the Authorization for the GMP “Human Drug Manufacturing”.
LEKLI sh.p.k has invested in new manufacturing facilities and in the latest technology in compliance with the GMP requirements, because we recognize the importance of treatment for patients with rare and life-threatening diseases in the Republic of Albania. The GMP authorization, following the full auditing carried out by the MoHSP, is an evidence of the hard work and dedication of the LEKLI sh.p.k employees.
I wish for this dedication to also continue in the future, to allow us to meet the specific needs of the country, which are difficult for the domestic and foreign pharmaceutical industry to cover” stated Dr. Luan Lekli, President of LEKLI sh.p.k.
